Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.
Roblin, X, S Nancey, K Papamichael, F Mechi, J Ouvrier-Buffet, A L Charlois, A S Peaucelle, et al. 2026. “Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.”. United European Gastroenterology Journal 14 (3): e70207.